Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on: June 22,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on:June 22,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on: March 30,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on:March 30,2024

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with

Updated on: December 22,2023

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with

Updated on:December 22,2023

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on: January 30,2024

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on:January 30,2024

Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Updated on: January 07,2024

Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Updated on:January 07,2024

Study tests new vaccine for precancerous cervical cells

by Kelsey Herbers,Vanderbilt UniversityCredit: CC0 Public DomainVanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeuti

Updated on: March 01,2024

Study tests new vaccine for precancerous cervical cells

by Kelsey Herbers,Vanderbilt UniversityCredit: CC0 Public DomainVanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeuti

Updated on:March 01,2024

Study finds new feature indicative of gastrointestinal tumor recurrence

by CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurre

Updated on: January 28,2024

Study finds new feature indicative of gastrointestinal tumor recurrence

by CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurre

Updated on:January 28,2024

Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

by Bradley J. FikesCancer cell during cell division. Credit: National Institutes of HealthA promising cancer drug, discovered in San Diego and later discarded for safety concerns, has at last been app

Updated on: April 22,2024

Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

by Bradley J. FikesCancer cell during cell division. Credit: National Institutes of HealthA promising cancer drug, discovered in San Diego and later discarded for safety concerns, has at last been app

Updated on:April 22,2024

Natural killer cells may open lifesaving cancer treatements to more patients

by University of Central FloridaUCF College of Medicine cancer researcher Alicja Copik has just discovered a way to make that therapy viable to thousands by using the body's own natural kille

Updated on: April 01,2024

Natural killer cells may open lifesaving cancer treatements to more patients

by University of Central FloridaUCF College of Medicine cancer researcher Alicja Copik has just discovered a way to make that therapy viable to thousands by using the body's own natural kille

Updated on:April 01,2024

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on: November 11,2024

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on:November 11,2024

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Updated on: January 15,2024

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Updated on:January 15,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on: January 10,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on:January 10,2024